生体インピーダンスデバイスの世界市場：2024-2031年

生体インピーダンスデバイス市場は、予測期間（2024-2031年）にCAGR 9.6%で成長すると予測されています。生体インピーダンスデバイスは、安全な電流を使用するため、体組成を測定するために放射線の代わりに使用されます。これらは操作が簡単で、より速く、よりコンパクトで、トレーニングが不要で、中にはハンドヘルドタイプもあります。消化器病学、慢性炎症、術後サーベイランス、スポーツ科学など、数多くの治療領域で生体インピーダンスデバイスが幅広く利用されています。

市場力学

フィットネスおよび体重管理ガジェットへの需要の高まり

体重管理やフィットネス愛好家にとってますます重要になっているパラメータである体組成に関する詳細な情報を提供するガジェットの能力が、その普及につながりました。糖尿病や肥満といった長期的な健康状態の発生が需要を押し上げています。生体インピーダンス分析により、筋肉量や体脂肪率を非侵襲的に追跡できるため、これらの疾患の管理に役立ちます。

生体インピーダンスデバイスの利用拡大

生体インピーダンスデバイスは、コスト効率の高いヘルスケアシステムソリューションの時代において、プロアクティブモニタリングの力をエンドユーザーの手にしっかりと委ねることで、非常に魅力的な価値提案を提供します。今後数年間は、この動向と予防的措置の拡大により、生体インピーダンスデバイス市場がさらに活性化すると予想されます。

市場セグメンテーション

• 製品タイプに基づき、市場は単一周波数生体インピーダンスデバイスと複数周波数生体インピーダンスデバイスに二分されます。
• モダリティ別では、有線生体インピーダンスデバイスと無線生体インピーダンスデバイスに二分されます。
• エンドユーザー別では、病院、専門クリニック、リハビリセンター、その他（外来手術センター）に区分されます。

病院が最大セグメントと予測

生体インピーダンスデバイスは、医師が体組成分析を行う際に使用され、その結果は重症患者の体液状態のモニタリング、肺機能の評価、適切な栄養介入の提供に活用されます。さらに、標準的な病院業務にこれらの機器を統合することで、より価値のある患者ケアのデータポイントが得られるため、非常に促進されています。

地域別展望

生体インピーダンスデバイスの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

手頃な価格の医療機器に投資するアジア太平洋諸国。

• 中国は人口が多いため、さまざまな予算やニーズに対応するさまざまな生体インピーダンスデバイスメーカーが存在する強力な市場です。これらにより、生体インピーダンスデバイスメーカーにとって有利な展望が開ける。

北米が主要市場シェアを占める

高度な医療インフラの存在、医療費の高騰、糖尿病人口の増加などが、同地域の市場成長における高シェアの主な要因です。また、生体インピーダンスデバイスの主要エンドユーザーである大手病院の存在も、同地域の市場成長を後押ししています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要市場動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• General Electric Company
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Inbody Co., Ltd
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Omron Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 生体インピーダンスデバイスの世界市場：製品タイプ別
  • 単一周波数生体インピーダンスデバイス
  • 複数周波数生体インピーダンスデバイス
• 生体インピーダンスデバイスの世界市場：モダリティ別
  • 有線生体インピーダンスデバイス
  • 無線生体インピーダンスデバイス
• 生体インピーダンスデバイスの世界市場：エンドユーザー別
  • 病院
  • 専門クリニック
  • リハビリセンター
  • その他（外来手術センター）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Akern Srl
• Biodynamics Corp.
• Bioparhom
• Bodystat Ltd.
• Charder Electronic Co. Ltd
• EVOLT IOH Pty Ltd
• Fook Tin Group Holding Ltd.
• Fresenius Medical Care
• ImpediMed Ltd.
• InBody Co. Ltd.
• Lumsail Industrial Inc.
• Maltron International Ltd.
• RJL Systems, Inc.
• SELVAS AI Inc.
• SMT Medical GmbH
• Tanita Corp.
• Xiaomi Inc.

LIST OF TABLES

• 1. Global Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
• 2. Global Single-Frequency Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Multiple-Frequency Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
• 5. Global Wired Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 6. Global Wireless Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
• 8. Global Bioimpedance Device For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Bioimpedance Device For Specialty Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Bioimpedance Device For Rehabilitation Centers Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Bioimpedance Device For Other End-Users Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. Global Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 13. North American Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
• 14. North American Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
• 15. North American Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
• 16. North American Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
• 17. European Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
• 18. European Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
• 19. European Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
• 20. European Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
• 21. Asia-Pacific Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
• 22. Asia-Pacific Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
• 23. Asia-Pacific Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
• 24. Asia-Pacific Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
• 25. Rest Of The World Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
• 26. Rest Of The World Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
• 27. Rest Of The World Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
• 28. Rest Of The World Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Bioimpedance Device Market Share By Product Type, 2023 Vs 2031 (%)
• 2. Global Single-Frequency Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Multiple-Frequency Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Bioimpedance Device Market Share By Modality, 2023 Vs 2031 (%)
• 5. Global Wired Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
• 6. Global Wireless Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Bioimpedance Device Market Share By End-Users, 2023 Vs 2031 (%)
• 8. Global Bioimpedance Device For Hospitals Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Bioimpedance Device For Specialty Clinics Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Bioimpedance Device For Rehabilitation Centers Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Bioimpedance Device For Other End-Users Market Share By Region, 2023 Vs 2031 (%)
• 12. Global Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
• 13. US Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 14. Canada Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 15. UK Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 16. France Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 17. Germany Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 18. Italy Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 19. Spain Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 20. Rest Of Europe Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 21. India Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 22. China Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 23. Japan Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 24. South Korea Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 25. Rest Of Asia-Pacific Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 26. Latin America Bioimpedance Device Market Size, 2023-2031 ($ Million)
• 27. Middle East And Africa Bioimpedance Device Market Size, 2023-2031 ($ Million)

Bioimpedance Device Market Size, Share & Trends Analysis Report by Product Type (Single-Frequency Bioimpedance Devices, and Multiple-Frequency Bioimpedance Devices), by Modality (Wired Bioimpedance Devices, and Wireless Bioimpedance Devices), and by End-Users (Hospitals, Specialty Clinics, Rehabilitation Centers, and Others) Forecast Period (2024-2031)

Bioimpedance device market is anticipated to grow at a CAGR of 9.6% during the forecast period (2024-2031). Bioimpedance devices are used instead of radiation to determine body composition, as they employ a safe electrical current. These are easier to operate, faster, more compact, and require no training some of them are even handheld. Numerous therapeutic domains, such as gastroenterology, chronic inflammation, postoperative surveillance, sports science, and many more, make extensive use of bioimpedance devices.

Market Dynamics

Growing demand for fitness and weight management gadgets

The gadgets' capacity to provide detailed information on body composition, a parameter that is becoming more and more important for weight management and fitness enthusiasts, led to their widespread adoption. The occurrence of long-term health conditions like diabetes and obesity is driving up demand. The percentage of muscle mass and body fat can be tracked non-invasively with bioimpedance analysis, which helps manage these disorders.

Rising usage of bioimpedance devices

Bioimpedance devices offer an incredibly attractive value proposition by putting the power of proactive monitoring firmly in the hands of the end-user in an era of cost-effective healthcare system solutions. Over the next years, it is anticipated that this trend and the expansion of preventative measures will further fuel the market for bioimpedance devices.

Market Segmentation

• Based on product type, the market is bifurcated into single-frequency bioimpedance devices and multiple-frequency bioimpedance devices.
• Based on modality, the market is bifurcated into wired bioimpedance devices, and wireless bioimpedance devices.
• Based on end-users, the market is segmented into hospitals, specialty clinics, rehabilitation centers, and others including ambulatory surgical centers.

Hospitals are Projected to Emerge as the Largest Segment

Bioimpedance devices are used by doctors to conduct body composition analyses, the results of which are utilized to monitor the fluid status of critically ill patients, evaluate lung function, and provide the proper nutritional intervention. Additionally, the integration of these devices in standard hospital operations is highly promoted as they produce patient care data points with extra value.

Regional Outlook

The global bioimpedance device market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to invest in affordable healthcare devices.

• China's large population makes it a strong market with a range of bioimpedance device manufacturers catering to varying budgets and needs. These factors can present a favorable prospect for producers of bioimpedance devices.

North America Holds Major Market Share

The presence of advanced healthcare infrastructure, high healthcare expenditure, and the growing prevalence of diabetes among the population are some of the key contributors to the high share of the regional market growth. Apart from these, the presence of major hospitals that are the primary end-users of bioimpedance devices further caters to the regional market growth.

Market Players Outlook

The major companies serving the global bioimpedance device market include Inbody Co., Ltd., General Electric Company, Omron Corp., Fresenius Medical Care, and ImpediMed Ltd. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions among others to stay competitive in the market. For instance, in September 2022, GlucoRx announced the first multi-sensor non-invasive glucose monitoring. The GlucoRx BioXensor uses patented radio frequency technology alongside a multiple-sensor approach to measure blood glucose levels every minute reliably, accurately, and non-invasively.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. General Electric Company
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Inbody Co., Ltd
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Omron Corp.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Bioimpedance Device Market by Product Type
  • 4.1.1. Single-Frequency Bioimpedance Devices
  • 4.1.2. Multiple-Frequency Bioimpedance Devices
• 4.2. Global Bioimpedance Device Market by Modality
  • 4.2.1. Wired Bioimpedance Devices
  • 4.2.2. Wireless Bioimpedance Devices
• 4.3. Global Bioimpedance Device Market by End-Users
  • 4.3.1. Hospitals
  • 4.3.2. Specialty Clinics
  • 4.3.3. Rehabilitation Centers
  • 4.3.4. Others (Ambulatory Surgical Centers)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Akern Srl
• 6.2. Biodynamics Corp.
• 6.3. Bioparhom
• 6.4. Bodystat Ltd.
• 6.5. Charder Electronic Co. Ltd
• 6.6. EVOLT IOH Pty Ltd
• 6.7. Fook Tin Group Holding Ltd.
• 6.8. Fresenius Medical Care
• 6.9. ImpediMed Ltd.
• 6.10. InBody Co. Ltd.
• 6.11. Lumsail Industrial Inc.
• 6.12. Maltron International Ltd.
• 6.13. RJL Systems, Inc.
• 6.14. SELVAS AI Inc.
• 6.15. SMT Medical GmbH
• 6.16. Tanita Corp.
• 6.17. Xiaomi Inc.